Patents by Inventor Susanne Lindquist

Susanne Lindquist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220267469
    Abstract: The present invention relates to novel isolated antibodies and antigen-binding fragments thereof that bind to human Bile Salt-Stimulated Lipase (hBSSL). The antibodies and antigen-binding fragments thereof bind to a previously uncharacterized epitope, situated in the N-terminal part of hBSSL and identified as comprising the amino acid residues 7-12 and the amino acid residues 42-55. The 5 present invention also relates to the medical uses of the antibodies and/or the antigen-binding fragments thereof, in particular in treatment of inflammatory conditions, and to related pharmaceutical compositions.
    Type: Application
    Filed: July 10, 2020
    Publication date: August 25, 2022
    Inventors: Olle HERNELL, Susanne LINDQUIST, Lennart LUNDBERG, Helena PERSSON LOTSHOLM
  • Publication number: 20200291136
    Abstract: It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.
    Type: Application
    Filed: May 29, 2020
    Publication date: September 17, 2020
    Inventors: Olle Hernell, Susanne Lindquist, Lennart Gustav Lundberg
  • Publication number: 20160096899
    Abstract: It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.
    Type: Application
    Filed: September 28, 2015
    Publication date: April 7, 2016
    Inventors: OLLE HERNELL, SUSANNE LINDQUIST, LENNART GUSTAV LUNDBERG
  • Patent number: 9168299
    Abstract: It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.
    Type: Grant
    Filed: October 30, 2013
    Date of Patent: October 27, 2015
    Assignee: LIPUM AB
    Inventors: Olle Hernell, Susanne Lindquist, Lennart Gustav Lundberg
  • Publication number: 20140099323
    Abstract: It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.
    Type: Application
    Filed: October 30, 2013
    Publication date: April 10, 2014
    Inventors: OLLE HERNELL, SUSANNE LINDQUIST, LENNART GUSTAV LUNDBERG
  • Patent number: 8597650
    Abstract: It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.
    Type: Grant
    Filed: April 6, 2010
    Date of Patent: December 3, 2013
    Inventors: Olle Hernell, Susanne Lindquist, Lennart Gustav Lundberg
  • Publication number: 20120093829
    Abstract: It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.
    Type: Application
    Filed: April 6, 2010
    Publication date: April 19, 2012
    Inventors: Olle Hernell, Susanne Lindquist, Lennart Gustav Lundberg